India's Medicamen Biotech hits 3-mth high on US FDA cancer drug application

Medicamen Biotech

19/07/2023 09:55

** Shares of Indian drugmaker Medicamen Biotech  MEBI.NS 
soar as much as 7.79% at 775 rupees - highest since April 19 
    ** Co said it successfully filed first abbreviated new drug
application (ANDA) with U.S. FDA for its anti-cancer drug
Bortezomib  
    ** *Stock sees sharpest intraday gain since May 26; to snap
five straight sessions of losses if gains hold  
    ** More than 60,222 shares changed hands by 2:07 P.M. IST,
4.6x 30-day avg 
    ** Stock down 8.5% this year as of last close

 (Reporting by Hritam Mukherjee in Bengaluru)
 ((Hritam.Mukherjee@thomsonreuters.com;))